Quest Diagnostics Incorporated (NYSE: DGX), a leading provider of diagnostic information services, today announced financial results for the first quarter ended March 31, 2025. Quest Diagnostics ...

Quest Diagnostics Inc.’s stock rose 3% early Tuesday, after the company posted better-than-expected first-quarter earnings and backed its full-year guidance, but acknowledged the early part of the ...

Quest Diagnostics (DGX) excels in diagnostics services but trades at a high valuation. Valuation analysis shows DGX trading ...

Return on Equity (ROE): Quest Diagnostics's ROE is below industry standards, pointing towards difficulties in efficiently utilizing equity capital. With an ROE of 3.24%, the company may encounter ...

Quest Diagnostics DGX is set to release its first-quarter 2025 results on April 22, before the market opens. The renowned diagnostics provider posted adjusted earnings per share (EPS) of $2.23 in ...

Laboratory operator Quest Diagnostics beat Wall Street estimates for first-quarter profit on Tuesday, helped by robust demand for its diagnostic tests.

Quest Diagnostics Inc. closed 1.22% short of its 52-week high of $178.87, which the company achieved on March 10th.